Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
ACMG Board Statement Regarding 2018 ACMG Annual Meeting to Be Held in Charlotte, NC and Discriminatory Legislation
-
ACMG Efforts Lead AMA Resolution 122 to Support Coverage of Medical Food Products
-
ACMG Response to Expansion of Direct-to-Consumer Genetic Testing
-
ACMG Letter to Congress Supporting the Accurate Education for Prenatal Screenings Act (HR 3441)
-
Joint Comments to CMS Concerning MolDx Program, Medicare Coverage, and Impact on MoPath Gapfill Determinations
-
ACMG Letter to Palmetto GBA Requesting Reconsideration of Cytogenetic Microarray Coverage
-
ACMG Comments to NIH about Development of the Genetic Test Registry
-
ACMG Letter Regarding California Assembly Bill 2300 (2010)
-
ACMG Letter Regarding Hawaii Senate Bill 1805 (2008) – Requesting Amendments